...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Long term efficacy and patient satisfaction of microvascular decompression and gamma knife radiosurgery for trigeminal neuralgia
【24h】

Long term efficacy and patient satisfaction of microvascular decompression and gamma knife radiosurgery for trigeminal neuralgia

机译:微血管减压和伽玛刀放射治疗三叉神经痛的长期疗效和患者满意度

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of our study was to evaluate the long term efficacy of microvascular decompression (MVD) and gamma knife radiosurgery (GKRS) with respect to pain relief and patient satisfaction. Both these modalities are accepted modalities of treatment for intractable trigeminal neuralgia. We excluded deceased patients, those who had a prior intervention and those requiring an additional intervention following initial treatment. A total of 69 patients were included in the study. Of these, 49 patients underwent treatment by GKRS and 20 by MVD. Pain status was assessed using the Barrow Neurological Institute (BNI) pain scale. The median follow up was 5.3 years. There was no significant difference between the two groups with respect to initial pain relief (100% MVD, 84% GKRS; p'0.055). There was no significant difference in pain recurrence between the two groups (39% GKRS, 20% MVD; p=0.133). At last follow up, 85% of patients who underwent MVD had total pain relief (BNI scale I) compared to only 45% of GKRS patients (p=0.002). There was no significant difference in the patient satisfaction with respect to undergoing the same procedure again (90% MVD, 69% GKRS; p=0.1) and recommending it to family members (95% MVD, 84% GKRS; p = 0.2). MVD offered total pain relief in a significantly higher number of patients than GKRS. There was no significant difference in the patient satisfaction rate between the two groups. (C) 2015 Elsevier Ltd. All rights reserved.
机译:我们研究的目的是评估微血管减压术(MVD)和伽玛刀放射外科手术(GKRS)在缓解疼痛和患者满意度方面的长期疗效。这两种方式都是顽固性三叉神经痛的公认治疗方式。我们排除了已故患者,先前接受过干预的患者以及初次治疗后需要额外干预的患者。该研究总共包括69名患者。其中,49例接受了GKRS治疗,20例接受了MVD治疗。使用巴罗神经病学研究所(BNI)疼痛量表评估疼痛状态。中位随访时间为5。3年。两组在初始疼痛缓解方面无显着差异(100%MVD,84%GKRS; p'0.055)。两组之间疼痛复发没有显着差异(39%GKRS,20%MVD; p = 0.133)。在最后一次随访中,接受MVD的患者中有85%的患者可以完全缓解疼痛(BNI I级),而GKRS患者中只有45%的患者(p = 0.002)。再次接受相同手术(90%MVD,69%GKRS; p = 0.1)并推荐给家庭成员(95%MVD,84%GKRS; p = 0.2),患者满意度没有显着差异。 MVD可以比GKRS显着提高患者的总疼痛缓解率。两组之间的患者满意度没有显着差异。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号